Health-related quality of life in Thai Thalassemic children treated with iron chelation

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 4, 2011, Pages 951-959

  Torcharus, Kitti ^a   Pankaew, Tidarat ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

Health related quality of life; Iron chelation; Thalassemic children

Indexed keywords

EID: 80054950878     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Abetz L, Baladi JF, Jones P, Rofail D. The impact of iron overload and its treatment on quality of life: results from a literature review. Health Qual Life Outcomes 2006; 4: 73.
2. Borgna-Pignatti C. Modern treatment of thalassaemia intermedia. Br J Haematol 2007; 138: 291-304.
3. Cappellini MD, Bejaoui M, Agaoglu L, et al. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther 2007; 29: 909-17.
4. Cappellini MD, Piga A. Current status in iron chelation in hemoglobinopathies. Curr Mol Med 2008; 8: 663-74.
5. Ceci A, Baiardi P, Catapano M, et al. Risk factors for death in patients with beta-thalassemia major: results of a case-control study. Haematologica 2006; 91: 1420-1.
6. Daar S, Pathare AV. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann Hematol 2006; 85: 315-9.
7. Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health Related Quality of Life in Malaysian children with thalassaemia. Health Qual Life Outcomes 2006; 4: 39.
8. Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of sample size in health studies. Chichester: John Wiley and Sons, 1990.
9. Messina G, Colombo E, Cassinerio E, et al. Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med 2008; 3: 339-43.
10. Osborne RH, De Abreu Lourenco R, Dalton A, et al. Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study.Value Health 2007; 10: 451-6.
11. Pakbaz Z, Treadwell M, Yamashita R, et al. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann NY Acad Sci 2005; 1054: 457-61.
12. Panich V, Pornpatkul M, Sriroongrueng W. The problem of thalassemia in Thailand. Southeast Asian J Trop Med Public Health 1992; 23 (suppl 2): 1-6.
13. Payne KA, Rofail D, Baladi JF, et al. Iron chelation therapy: clinical effectiveness, economic burden and quality of life in patients with iron overload. Adv Ther 2008; 25: 725-42.
14. Resnick I B, Aker M, Tsirigotis P, et al. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. Bone Marrow Transplant 2007; 40: 957-64.
15. Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr 2007; 74: 727-30.
16. Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disorders 2010; 10: 1.
17. Vichinsky EP. Changing patterns of thalassemia worldwide. Ann NY Acad Sci 2005; 1054: 18-24.